Physician profile
Garrett Wright
NPI 1306131982
$72,778.00
in general payments reported to CMS, 2019-2025
34 companies · $1,727 in 2025
The $1,727 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2020: $4,583 · 2021: $4,702 · 2022: $11K · 2023: $1,439 · 2024: $3,004 · 2025: $1,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,070 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,070.36 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $58,950.36 | 2019-2024 | Omnia, Senza |
| Boston Scientific Corporation | $5,434.89 | 2019-2025 | Wavewriter Alpha Prime 16, Wallstent Rp Endoprosthesis |
| Abbott Laboratories | $2,488.89 | 2019-2023 | Proclaim |
| Medtronic, INC. | $1,175.95 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Globus Medical, INC. | $901.24 | 2025 | Senza, Omnia |
| Medtronic USA, INC. | $435.72 | 2019-2020 | |
| Nalu Medical, INC. | $387.99 | 2021-2022 | |
| Saluda Medical Americas, INC. | $352.12 | 2023-2025 | Evoke, Evoke Scs |
| Scilex Pharmaceuticals INC. | $284.52 | 2019-2023 | Ztlido |
| Vertiflex, INC. | $256.21 | 2019 | |
| Abbvie INC. | $251.09 | 2022-2025 | Ubrelvy, Botox |
| Relievant Medsystems, INC. | $242.25 | 2022-2023 | Intracept |
| Horizon Therapeutics Plc | $168.67 | 2019-2020 | |
| Stryker Corporation | $152.86 | 2019 | |
| Si-Bone, INC. | $141.43 | 2019-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $137.50 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $127.05 | 2021-2023 | Relistor |
| Ibsa Pharma INC. | $111.15 | 2021-2024 | Tirosint, Licart, Licart |
| Collegium Pharmaceutical, INC. | $92.72 | 2023 | Belbuca |
| Allergan, INC. | $86.83 | 2019-2022 | |
| Grt US Holding, INC. | $71.21 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $69.78 | 2022 | |
| Vertos Medical, INC. | $68.68 | 2020 | |
| Pacira Therapeutics, INC. | $66.44 | 2019-2021 | |
| Spr Therapeutics, INC | $52.03 | 2021-2025 | Sprint Pns System |
| Bioventus LLC | $48.63 | 2021-2022 | |
| Pfizer INC. | $46.61 | 2019 | |
| Foundation Fusion Solutions, LLC | $38.40 | 2023 | |
| Amgen INC. | $33.57 | 2020 | |
| Merck Sharp & Dohme LLC | $32.16 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $24.33 | 2025 | Zilretta, Iovera |
| Averitas Pharma INC. | $18.36 | 2024 | Qutenza |
| Radius Health, INC. | $14.92 | 2021 | |
| Almatica Pharma LLC | $13.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Garrett Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.